Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong
· Delayed Price · Currency is HKD 3.340
+0.240 (7.74%)
Mar 10, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Market Cap
Hua Medicine (Shanghai) has a market cap or net worth of 3.06 billion as of March 9, 2026. Its market cap has increased by 86.93% in one year.
Market Cap
3.06B
Enterprise Value
2.24B
Revenue
406.16M
Ranking
n/a
PE Ratio
2.59
Stock Price
3.34
Market Cap Chart
Since September 14, 2018, Hua Medicine (Shanghai)'s market cap has decreased from 8.71B to 3.06B, a decrease of -64.83%. That is a compound annual growth rate of -13.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VISEN Pharmaceuticals | 3.37B |
| Jacobson Pharma Corporation | 2.56B |
| Essex Bio-Technology | 2.29B |
| Golden Throat Holdings Group Company | 2.27B |
| JBM (Healthcare) | 2.22B |
| Edding Genor Group Holdings | 5.34B |
| Dawnrays Pharmaceutical (Holdings) | 1.74B |
| China Shineway Pharmaceutical Group | 6.90B |